{"id":"W3123927868","doi":"10.1177/1078155220984252","title":"Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Adverse effect; Lung cancer; Oncology; Melanoma; Dosing; Cancer; Clinical endpoint; Ipilimumab; Area under the curve; Retrospective cohort study; Immunotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001758672,0.0001811329,0.0004276096,0.0004143394,0.0001608098,0.0003736624,0.0002115261,0.0002923478,0.0004731297],"category_scores_gemma":[0.006847369,0.00015512,0.0004252456,0.0005247496,0.0001746167,0.0003888799,0.0001718479,0.0004038668,0.0001383756],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003621489,"about_ca_system_score_gemma":0.0001928101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003271508,"about_ca_topic_score_gemma":0.0003911714,"domain_scores_codex":[0.9985709,0.0005158103,0.0002131896,0.0002951349,0.0003510376,0.00005391793],"domain_scores_gemma":[0.9939318,0.00185311,0.003289761,0.0003650911,0.0003594948,0.0002007967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001533815,0.00005360226,0.9889778,0.00002275442,0.0002261248,0.00008204357,0.00003283184,0.0004403033,0.001132366,0.0000113712,0.00004884508,0.007438177],"study_design_scores_gemma":[0.0000512713,0.001196317,0.9956746,0.000006105675,0.00007581969,0.0006604568,0.00002800186,0.001519922,0.0004923165,0.00003444284,0.0002554998,0.000005160308],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988919,0.0005080522,0.0002345848,0.000027204,0.000003166033,0.000009503947,0.000112227,0.000004372422,0.0002089912],"genre_scores_gemma":[0.9996183,0.00004935997,0.0001251963,0.0000183239,0.000006330542,0.000004172247,0.0001494234,0.00000169581,0.00002719218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001758672,"threshold_uncertainty_score":0.009300888,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01352085906953321,"score_gpt":0.3491205488471297,"score_spread":0.3355996897775965,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}